Merck Sharp & Dohme Corp. v. Genentech, Inc. > Summary
Court Case Number PGR2021-00039
Filing Date Jan 20, 2021
Institution Decision Date Jul 24, 2021
Decision Date Jul 24, 2021
Court Patent Trial and Appeal Board
Status Institution Denied
Administrative JudgesRobert A. Pollock, Susan L. C. Mitchell, Christopher G. Paulraj
Judge Writing the Final DecisionRobert A. Pollock
Claims Challenged in the Petition: 1, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
Plaintiff
Defendant
Plaintiff Attorneys
6Merck Sharp & Dohme
Attorney Name: Matthew A. Traupman
Quinn Emanuel Urquhart & Sullivan
Merck Sharp & Dohme
Attorney Name: Amanda K. Antons
Quinn Emanuel Urquhart & Sullivan
Merck Sharp & Dohme
Attorney Name: Richard C. Billups
Merck & Co., Inc.
Merck Sharp & Dohme
Attorney Name: James McDonnell
Quinn Emanuel Urquhart & Sullivan
Merck Sharp & Dohme
Attorney Name: Jeffrey Ravetch
Quinn Emanuel Urquhart & Sullivan
Defendant Attorneys
2Genentech, Inc
Attorney Name: Adam R. Brausa
Morrison & Foerster
Genentech, Inc
Attorney Name: Daralyn J. Durie
Morrison & Foerster
Related Patents
Doc No | Title | Issue date |
---|---|---|
10626174 | Methods of treating cancer using PD-1 axis binding antagonists and TIGIT inhibitors | Apr 21, 2020 |